ArticleHealth economics review2026
Can the remuneration scheme of general practitioners affect their antibiotic prescription behaviour?
Article in Health economics review, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- General practitioners' type of remuneration and antibiotic prescriptions. An analysis of patient switches using nationwide registry data.Scandinavian journal of primary health care · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAntibiotic resistance poses a significant global health threat, exacerbated by over-prescription of antibiotics, which often happens in primary care for respiratory tract infections (RTIs). Studies indicate that up to half of these prescriptions may be unnecessary. Little is known about how general practitioners' (GPs) remuneration schemes influence prescribing. GPs compensated via fee-for-service (FFS) and capitation (CAP) may face stronger incentives to prescribe antibiotics compared to salaried GPs, as prescriptions can signal quality, reduce consultation time, and aid patient retention - critical where reimbursements depend on consultations and list size. This study examines how GP remuneration influences antibiotic prescribing for RTIs using Norwegian register data.
methodsWe utilized linked registry data (2015-2019) from the Control and Payment of Health Reimbursements Database (KUHR), National GP Registry, Norwegian Prescribed Drug Registry (NorPD), and Statistics Norway. We matched antibiotic prescriptions to patient-GP contacts for RTIs. The dataset covers regular GPs (mixed FFS/CAP or fixed salary) and locum GPs (FFS or salary). OUTCOMES: (1) probability of antibiotic prescription during RTI contacts; (2) probability of selecting non-phenoxymethylpenicillin (non-PcV). We used linear probability, logit, and probit models, controlling for GP, patient, contact, and practice attributes. To mitigate selection bias, we exploited within-GP variation among those who switched remuneration type during the study period.
resultsRegular FFS/CAP GPs had a 12-15% higher relative probability of prescribing antibiotics for RTIs than salaried GPs, especially at initial contacts. When prescribing, they were 9-11% more likely to choose non-PcV. Switchers analyses showed that FFS/CAP increased prescription rates by 14% and non-PcV choice by 8%. Among locums, we did not find any significant difference in overall prescription rates between FFS and salary, but FFS locums favoured non-PcV by 7%.
conclusionsRemuneration schemes may influence antibiotic prescribing behaviour. FFS/CAP is linked to higher prescription rates and broader-spectrum antibiotic use among regular GPs, likely due to patient retention and time-efficiency incentives. Policy interventions, such as monitoring of prescriptions depending on the remuneration type or adjustments to the remuneration scheme (e.g., antibiotic-related pay-for-performance), could promote prudent prescribing. Further research is needed on prescription appropriateness and quality impacts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.